How the Cyprus IP Box is calculated: the nexus fraction explained (2026)

How is the Cyprus IP Box calculated?

For 2026 corporate examples: UE = min(30% × QE, A + R); OE = QE + A + R; N = min(1, (QE + UE) / OE). The deduction is 80% × OI × N. Taxable IP income is OI minus that deduction, not merely 20% of the nexus-adjusted portion. At 15%, the effective rate on OI is 15% × (1 − 80% × N).

OI is net income attributable to the qualifying asset. QE is qualifying R&D expenditure; A is acquisition cost; R is related-party R&D. Use the statutory categories and historical expenditure records.

Calculate the capped uplift and nexus fraction, then subtract the deduction from the full OI. The portion outside the nexus-adjusted profit remains taxable. A zero denominator does not establish full nexus.

The four terms you need: OI, QE, UE and OE

Every figure in the Cyprus IP Box formula reduces to four defined terms, and getting the classification right is where most of the tax outcome is decided.

• Identify royalties, licences, compensation and the supported IP component of product or service income. Deduct attributable expenses to calculate net income. Non-capital disposal income requires separate analysis; capital gains should not automatically be included in the IP income base.
• QE (qualifying expenditure): your own in-house R&D plus R&D outsourced to unrelated third parties. This counts even if the work was performed abroad.
• UE (uplift expenditure): a 30% top-up on QE, capped so it can never exceed the excluded costs below.
• OE (overall expenditure): QE plus acquisition cost of the IP plus R&D outsourced to related parties.
• Excluded from QE (and added to OE): the cost of acquiring the IP and any R&D paid to related/group companies.

The nexus fraction, step by step

The nexus fraction is (QE + UE) ÷ OE, capped at 100%. It expresses the proportion of your development effort that Cyprus treats as genuine substance, and it directly scales the profit that can enjoy the 80% deduction.

Because acquisition costs and related-party R&D sit only in the denominator (OE) and never in QE, relying on bought-in IP or group R&D pushes the fraction down. Conversely, a company that develops its own asset in-house has QE equal to OE, so the fraction is 100% before the uplift is even considered.

The cap at 100% matters: the 30% uplift can lift a partly-outsourced or partly-acquired asset back towards full benefit, but it can never take the fraction above 1. The uplift is a smoothing tool, not a way to manufacture relief beyond your actual profit.

• Numerator: QE + UE (your qualifying spend plus the 30% uplift).
• Denominator: OE = QE + acquisition cost + related-party R&D, not every accounting expense.
• Uplift = the lower of 30% of QE, or the total of acquisition cost + related-party R&D.
• Result is capped at 100% — never more.
• Pure in-house development ⇒ fraction = 100%.

Why the 30% uplift exists

The 30% uplift exists to stop the nexus rules from punishing normal, commercially sensible business decisions. A modest amount of acquisition or group R&D would otherwise sharply cut the fraction, even where the company did most of the real work itself.

So the rule adds up to 30% of your qualifying expenditure back into the numerator — but only up to the amount of the costs that were excluded from QE (acquisition plus related-party R&D). If you had no excluded costs, there is nothing for the uplift to compensate for, and it contributes nothing.

In practice the uplift means a business can acquire a foundational asset or use a group R&D centre for part of a project and still reach, or nearly reach, the full benefit — provided the bulk of the value was created through its own or unrelated-party effort.

• Uplift = min(30% × QE, acquisition cost + related-party R&D).
• It only helps where excluded costs exist.
• It cannot push the nexus fraction above 100%.
• Purpose: fair treatment of mixed-source development, not a loophole.

Worked example (a): internally developed IP → ~3%

A Cyprus software company builds its product entirely in-house with its own developers. There is no acquisition cost and no related-party R&D, so qualifying expenditure equals overall expenditure and the nexus fraction is 100%.

Take net IP income (OI) of €1,000,000. The nexus ratio is 100%, so the qualifying profit is the full €1,000,000. The 80% deduction removes €800,000, leaving €200,000 taxable. At 15% corporate income tax, the tax due is €30,000 — an effective rate of about 3% on the IP income.

• OI: €1,000,000
• QE = OE (all own R&D) ⇒ nexus ratio = 100%
• Qualifying profit: €1,000,000 × 100% = €1,000,000
• 80% deduction: −€800,000 ⇒ taxable €200,000
• Tax at 15%: €30,000 → effective rate ≈ 3%

Worked example (b): acquired IP plus third-party R&D → partial benefit

OI = €1,000,000; QE = €400,000; A = €300,000; R = €0. OE = €700,000 and UE = min(€120,000, €300,000) = €120,000.

N = €520,000 / €700,000 = 74.285714…%. Qualifying profit = €742,857.14 and the 80% deduction = €594,285.71.

Taxable IP income = €1,000,000 − €594,285.71 = €405,714.29. At 15%, total tax on OI is €60,857.14, or approximately 6.09%. Keep full precision until the final rounding; the tax is not €22,200 or 2.2%.

Worked example (c): acquired IP plus related-party R&D → little or no benefit

Finally, consider a company that acquired the IP and had all further development carried out by a related group entity. Here almost nothing lands in qualifying expenditure: acquisition cost and related-party R&D are both excluded from QE and sit only in overall expenditure.

If QE is near zero and OE is, say, €700,000, the uplift (30% of a near-zero QE) is also near zero. The nexus ratio collapses towards 0%, so there is little or no qualifying profit and therefore no 80% deduction. The IP income is effectively taxed at the standard 15% corporate rate.

This is the intended result of the nexus approach: a company that neither developed the asset itself nor used unrelated parties has not created the substance the regime rewards, so it does not receive the benefit.

• OI: €1,000,000
• QE (own + unrelated R&D): ≈ €0
• OE (acquisition + related-party R&D): €700,000
• Uplift: ≈ €0 (30% of near-zero QE)
• Nexus ratio: ≈ 0% ⇒ negligible qualifying profit
• Result: income taxed at the standard 15% — no meaningful IP Box benefit

Other points that affect the calculation

A disposal requires classification: capital and trading transactions can receive different treatment. Do not assume every sale of software or shares is tax-free.

Track the relevant asset separately. Any permitted grouping needs support; it is not a licence to average unrelated assets. The 3% corporate illustration assumes full nexus and the 15% rate from 2026.